Metastasized LN | Non-metastasized LN | |
---|---|---|
Lymph node size | ||
< 10 mm | 30 (37.0%) | 2671 (52.5%) |
≥ 10 mm | 51 (63.0%) | 2421 (47.5%) |
p = 0.007 | ||
Lipomatous atrophy (%) | ||
≤ 30 | 68 (84.0%) | 3396 (66.7%) |
31–60 | 7 (8.6%) | 671 (13.2%) |
≥ 61 | 6 (7.4%) | 1025 (20.1%) |
p = 0.004 | ||
Framework fibrosis | ||
Non | 61 (75.3%) | 3553 (69.8%) |
Low | 15 (18.5%) | 1209 (23.7%) |
Moderate | 4 (4.9%) | 304 (6.0%) |
High | 1 (1.2%) | 26 (0.5%) |
p = 0.53 | ||
Capsular fibrosis | ||
With | 12 (14.8%) | 1802 (35.4%) |
Without | 69 (85.2%) | 3290 (64.6%) |
p < 0.001 | ||
Calcifications | ||
With | 29 (35.8%) | 2347 (46.1%) |
Without | 52 (64.2%) | 2745 (53.9%) |
p = 0.072 |